Current reports
6-K
Cresco Labs Reports Fourth Quarter & Full Year 2023 Financial Results Demonstrating Significant Profitability and Cash Flow Improvements
13 Mar 24
6-K
Current report (foreign)
6 Feb 24
6-K
Unaudited Condensed Interim Consolidated Financial Statements
15 Nov 23
6-K
Current report (foreign)
16 Aug 23
6-K
Cresco Labs and Columbia Care Mutually Agree to Terminate Merger
31 Jul 23
6-K
Cresco Labs and Columbia Care Provide Update on Transaction
30 Jun 23
6-K
Unaudited Condensed Interim Consolidated Financial Statements
25 May 23
6-K
Cresco Labs Announces Fourth Quarter & Full Year 2022 Results
16 Mar 23
6-K
Current report (foreign)
17 Nov 22
6-K
Cresco Labs Announces Board Director Sidney Dillard’s Resignation
25 Oct 22
Registration and prospectus
F-X
Appointment of agent for service of process by issuers registering securities
17 Aug 23
F-10
Registration of securities (Canada)
17 Aug 23
D
$62.13M in equity, sold $62.13M, 76 investors
21 Dec 21
F-10/A
Registration of securities (Canada) (amended)
23 Apr 21
F-10
Registration of securities (Canada)
1 Mar 21
S-8
Registration of securities for employees
1 Mar 21
F-X
Appointment of agent for service of process by issuers registering securities
14 Jan 21
40FR12G
Initial registration of securities (Canada)
13 Jan 21
Proxies
No filings
Ownership
SC 13D
Cresco Labs / Cresco Labs ownership change
16 Feb 24
SC 13D
Cresco Labs / Cresco Labs ownership change
16 Feb 24
SC 13G
Cresco Labs / Cresco Labs ownership change
16 Feb 24
SC 13G
Cresco Labs / Cresco Labs ownership change
14 Feb 24
SC 13G
Cresco Labs / Cresco Labs ownership change
14 Feb 24
SC 13G
Cresco Labs / Cresco Labs ownership change
14 Feb 24
SC 13G
NOMURA HOLDINGS INC
14 Feb 24
SC 13G/A
Cowen Financial Products LLC
2 Feb 24
SC 13G/A
Cowen Financial Products LLC
23 Jan 23
SC 13G
Sampson Robert M
14 Feb 22